ֱ

TikTok Tics; COVID Vaccines and CVST; Predicting Brain Injury Outcomes

— News and commentary from the world of neurology and neuroscience

MedpageToday
Brain scan images with NeuroBreak in the center.

Tic-like behaviors after viewing certain videos differ from tics in Tourette's syndrome and may represent a socially driven functional movement disorder. (Movement Disorders)

People diagnosed with high blood pressure at ages 35-44 had and were more likely to develop dementia than people with normal blood pressure. (Hypertension)

Treatment with the 5-HT4 receptor agonist prucalopride (Prudac), a drug used to treat chronic idiopathic constipation, in young people. (Translational Psychiatry)

Mortality was very high in people with (CVST) who had thrombosis with thrombocytopenia syndrome after adenoviral vector COVID-19 vaccination, international registry data confirmed. (JAMA Neurology)

David Julius, PhD, of the University of California San Francisco, and Ardem Patapoutian, PhD, of the Scripps Research Institute in La Jolla, who independently discovered involved in pain or touch perception, won the 2021 Nobel Prize in Physiology or Medicine. (New York Times)

Only to the treatment dose approved by the FDA in Biogen's aducanumab (Aduhelm) clinical trials, even though Black older adults have higher rates of incident Alzheimer's disease than white people. (JAMA Neurology)

Neurofilament light, a marker of axonal injury, and progressive neurodegeneration after traumatic brain injury. (Science Translational Medicine)

Prescribing information for the migraine prevention drug erenumab (Aimovig) was updated last year to include elevated blood pressure, but researchers pointed out that erenumab of hypertension than placebo in clinical trials. (Headache)

A bested standard care for treating chronic back pain, a pilot trial showed. (PAIN Reports)

Catalyst Pharmaceuticals received a positive decision from an appeals court that upheld the FDA's approval of an amifampridine product (Ruzurgi) for pediatric Lambert-Eaton myasthenic syndrome, despite Catalyst's orphan drug exclusivity for its amifampridine (Firdapse) tablets.

  • Judy George covers neurology and neuroscience news for ֱ, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.